A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...

For decades, Jeff Card's family company was known for manufacturing the once ubiquitous tin boxes where people could buy ...

Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...

Analyst Marie Thibault of BTIG reiterated a Buy rating on Establishment Labs Holdings (ESTA – Research Report), retaining the price ...

Experts express enthusiasm after US health regulators approved the first new form of treatment for schizophrenia in decades.